Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Marksans Pharma's OCF Yield % or its related term are showing as below:
NSE:MARKSANS'
s OCF Yield % Range Over the Past 10 Years
Min: 3.78 Med: 0 Max: 3.78
Current: 3.78
During the past 13 years, the highest OCF Yield % of Marksans Pharma was 3.78%. The lowest was 3.78%. And the median was %.
NSE:MARKSANS's OCF Yield % is ranked better than 51.69% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 3.62
vs NSE:MARKSANS: 3.78
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Marksans Pharma OCF Yield % Related Terms
Marksans Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for Marksans Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MARKSANS vs LLY, JNJ, ABBV: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Marksans Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Marksans Pharma OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Marksans Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Marksans Pharma (NSE:MARKSANS) has a OCF Yield % of 3.78 as of Jul. 19, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Marksans Pharma and its competitors. Over the past decade, Marksans Pharma's OCF Yield % has ranged from 3.78 to 3.78. According to the industry distribution chart, Marksans Pharma ranks #486 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 48.3%.
Is Marksans Pharma's OCF Yield % too high?
Marksans Pharma's current OCF Yield % is 3.78. Over the past 10 years, this metric has ranged from a low of 3.78 to a high of 3.78. The Drug Manufacturers industry median OCF Yield % is 3.62. Marksans Pharma's value of 3.78 is 4.4% above this industry median. Based on the distribution chart, Marksans Pharma ranks #486 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Marksans Pharma has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Marksans Pharma's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Marksans Pharma ranks #486 out of 1006 companies for OCF Yield %. This puts Marksans Pharma in the upper half of its industry. The industry median OCF Yield % is 3.62. Marksans Pharma's value of 3.78 is 4.4% above this benchmark. Historically, Marksans Pharma's own OCF Yield % has ranged from 3.78 to 3.78 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.62, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Marksans Pharma's current OCF Yield % of 3.78 is 4.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Marksans Pharma and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Marksans Pharma's current OCF Yield % is 3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marksans Pharma stock overvalued right now?
Based on GuruFocus' analysis, Marksans Pharma (NSE:MARKSANS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹229.15, compared to a current price of ₹267.10 — trading 16.6% above its estimated fair value. The current OCF Yield % is 3.78 and 4.4% above the Drug Manufacturers industry median of 3.62. Marksans Pharma's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Marksans Pharma (NSE:MARKSANS), the current OCF Yield % is 3.78 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Marksans Pharma (NSE:MARKSANS) Overvalued in 2026?
Based on GuruFocus' analysis, Marksans Pharma stock appears to be overvalued.
The current stock price of ₹267.10 is trading 16.6% above its estimated GF Value™ of ₹229.15.
GuruFocus considers Marksans Pharma to be Modestly Overvalued.
Key valuation signals for NSE:MARKSANS:
OCF Yield %: 3.78
GF Value™: ₹229.15 vs. price of ₹267.10 (16.6% above fair value)
Industry Position: 4.4% above the Drug Manufacturers median (#486 of 1006)
No single metric tells the full story. See the NSE:MARKSANS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.
90GF Score
Get the complete analysis for NSE:MARKSANS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MARKSANS has been successfully added to your 
